Chugai Pharmaceutical Co's market cap is currently $80.48B. The company's EPS TTM is $1.551; its P/E ratio is 29.93; and it has a dividend yield of 1.37%. Chugai Pharmaceutical Co is scheduled to report earnings on January 30, 2025, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22	Dec 21	Dec 20
Income Statement
Total Revenue	¥ 1.17T	¥ 1.11T	¥ 1.26T	¥ 999.76B	¥ 786.95B
Gross Profit	¥ 831.20B	¥ 698.06B	¥ 783.70B	¥ 661.61B	¥ 513.48B
Operating Income	¥ 542.00B	¥ 439.17B	¥ 533.31B	¥ 421.90B	¥ 301.23B
EBITDA	¥ 568.39B	¥ 475.64B	¥ 562.66B	¥ 450.30B	¥ 328.72B
Net Income	¥ 387.32B	¥ 325.47B	¥ 374.43B	¥ 303.00B	¥ 214.73B
Balance Sheet
Cash & Short-Term Investments	¥ 996.35B	¥ 738.98B	¥ 503.11B	¥ 471.97B	¥ 378.62B
Total Assets	¥ 2.21T	¥ 1.93T	¥ 1.87T	¥ 1.54T	¥ 1.24T
Total Debt	¥ 0.00	¥ 13.46B	¥ 14.11B	¥ 16.04B	¥ 11.28B
Net Debt	¥ -540.20B	¥ -458.67B	¥ -208.06B	¥ -251.71B	¥ -201.05B
Total Liabilities	¥ 306.87B	¥ 306.97B	¥ 445.37B	¥ 350.68B	¥ 255.50B
Stockholders' Equity	¥ 1.90T	¥ 1.63T	¥ 1.42T	¥ 1.19T	¥ 980.00B
Cash Flow
Free Cash Flow	¥ 396.68B	¥ 335.67B	¥ 172.87B	¥ 206.76B	¥ 143.62B
Operating Cash Flow	¥ 447.60B	¥ 409.93B	¥ 244.11B	¥ 279.63B	¥ 205.03B
Investing Cash Flow	¥ -227.37B	¥ -37.29B	¥ -145.99B	¥ -118.93B	¥ -98.31B
Financing Cash Flow	¥ -141.01B	¥ -139.33B	¥ -145.64B	¥ -107.41B	¥ -99.50B

Currency in JPY

Chugai Pharmaceutical Co Earnings and Revenue History

Income Statement >

Chugai Pharmaceutical Co Debt to Assets

Balance Sheet >

Chugai Pharmaceutical Co Cash Flow

Cash Flow >

Chugai Pharmaceutical Co Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing